Regulus Therapeutics up 19% on raising $15M
- Regulus Therapeutics (NASDAQ:RGLS) enters securities purchase agreement in connection with a private placement to certain institutional investors and other accredited investors.
- The financing was led by the Federated Hermes Kaufmann Funds and New Enterprise Associates, with participation from additional existing shareholders.
- Closing is anticipated to occur on or about April 13, 2023.
- Gross proceeds of ~$15M are expected.
- The closing of the financing is subject to customary closing conditions.
- Investors have agreed to purchase 2.62M shares at a purchase price of $0.9001 per share.
- Stock price jumps 19% during pre-market hour.